融合微生物转谷氨酰胺酶蛋白G变体对天然IgG Fab片段的邻近位点特异性标记

IF 4.9 2区 生物学 Q1 BIOCHEMICAL RESEARCH METHODS
Koki Murozono , Riko Nishioka , Yoshirou Kawaguchi , Michio Kimura , Noriho Kamiya
{"title":"融合微生物转谷氨酰胺酶蛋白G变体对天然IgG Fab片段的邻近位点特异性标记","authors":"Koki Murozono ,&nbsp;Riko Nishioka ,&nbsp;Yoshirou Kawaguchi ,&nbsp;Michio Kimura ,&nbsp;Noriho Kamiya","doi":"10.1016/j.nbt.2025.08.004","DOIUrl":null,"url":null,"abstract":"<div><div>The fragment antigen-binding (Fab) fragment of IgG has been studied widely as a delivery vehicle for tumor-targeting drugs and dyes due to its high specificity and enhanced tumor penetration, which is attributed to its small size. Functionalizing Fab with chemical entities requires site-specific modification to preserve the binding ninity and ensure product homogeneity. In this study, we report a tag-free, site-specific labeling approach targeting a Lys residue in Fab using the recently developed engineered zymogen of microbial transglutaminase fused with an antibody-binding protein G. Fab of trastuzumab, prepared via papain digestion, was selectively modified at Lys 65 in the heavy chain with a glutamine-donor fluorescent substrate, achieving a high labeling efficiency (∼96 %). Bio-layer interferometry experiments confirmed that the modified Fab retained antigen-binding affinity (<em>K</em><sub>D</sub> = 5.71 ± 3.89 nM) comparable to its native counterpart (4.72 ± 3.19 nM). Confocal microscopy analysis demonstrated selective binding of the fluorescent-modified Fab to human epidermal growth factor receptor type2 (HER2)-positive SK-BR-3 cells, with negligible binding to HER2-negative MDA-MB-231 cells. The proposed strategy enables site-specific Fab modification without genetic engineering, offering a streamlined approach to producing homogeneous Fab conjugates for diagnostic imaging and therapeutic antibody engineering applications.</div></div>","PeriodicalId":19190,"journal":{"name":"New biotechnology","volume":"90 ","pages":"Pages 56-64"},"PeriodicalIF":4.9000,"publicationDate":"2025-08-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Proximity-based site-specific labeling of a native IgG Fab fragment by a fusion microbial transglutaminase-protein G variant\",\"authors\":\"Koki Murozono ,&nbsp;Riko Nishioka ,&nbsp;Yoshirou Kawaguchi ,&nbsp;Michio Kimura ,&nbsp;Noriho Kamiya\",\"doi\":\"10.1016/j.nbt.2025.08.004\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><div>The fragment antigen-binding (Fab) fragment of IgG has been studied widely as a delivery vehicle for tumor-targeting drugs and dyes due to its high specificity and enhanced tumor penetration, which is attributed to its small size. Functionalizing Fab with chemical entities requires site-specific modification to preserve the binding ninity and ensure product homogeneity. In this study, we report a tag-free, site-specific labeling approach targeting a Lys residue in Fab using the recently developed engineered zymogen of microbial transglutaminase fused with an antibody-binding protein G. Fab of trastuzumab, prepared via papain digestion, was selectively modified at Lys 65 in the heavy chain with a glutamine-donor fluorescent substrate, achieving a high labeling efficiency (∼96 %). Bio-layer interferometry experiments confirmed that the modified Fab retained antigen-binding affinity (<em>K</em><sub>D</sub> = 5.71 ± 3.89 nM) comparable to its native counterpart (4.72 ± 3.19 nM). Confocal microscopy analysis demonstrated selective binding of the fluorescent-modified Fab to human epidermal growth factor receptor type2 (HER2)-positive SK-BR-3 cells, with negligible binding to HER2-negative MDA-MB-231 cells. The proposed strategy enables site-specific Fab modification without genetic engineering, offering a streamlined approach to producing homogeneous Fab conjugates for diagnostic imaging and therapeutic antibody engineering applications.</div></div>\",\"PeriodicalId\":19190,\"journal\":{\"name\":\"New biotechnology\",\"volume\":\"90 \",\"pages\":\"Pages 56-64\"},\"PeriodicalIF\":4.9000,\"publicationDate\":\"2025-08-21\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"New biotechnology\",\"FirstCategoryId\":\"5\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1871678425000810\",\"RegionNum\":2,\"RegionCategory\":\"生物学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"BIOCHEMICAL RESEARCH METHODS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"New biotechnology","FirstCategoryId":"5","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1871678425000810","RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"BIOCHEMICAL RESEARCH METHODS","Score":null,"Total":0}
引用次数: 0

摘要

IgG片段抗原结合(Fab)片段由于其体积小,特异性高,可增强肿瘤穿透性,因此作为肿瘤靶向药物和染料的递送载体被广泛研究。用化学实体功能化Fab需要位点特异性修饰,以保持结合强度并确保产品的均匀性。在这项研究中,我们报道了一种无标签、位点特异性的标记方法,利用最近开发的微生物转谷氨酰胺酶工程酶原与抗体结合蛋白G.融合的Fab中的Lys残基,通过木瓜蛋白酶消化制备曲珠单抗的Fab,在重链中的Lys 65上选择性地修饰谷氨酰胺供体荧光底物,实现了高标记效率(~ 96 %)。生物层干涉实验证实,修饰后的Fab保留了与原物(4.72 ± 3.19 nM)相当的抗原结合亲和力(KD = 5.71 ± 3.89 nM)。共聚焦显微镜分析显示,荧光修饰的Fab与人表皮生长因子受体2型(HER2)阳性的SK-BR-3细胞选择性结合,与HER2阴性的MDA-MB-231细胞的结合可以忽略。所提出的策略使位点特异性Fab修饰无需基因工程,提供了一种简化的方法来生产用于诊断成像和治疗性抗体工程应用的均匀Fab偶联物。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Proximity-based site-specific labeling of a native IgG Fab fragment by a fusion microbial transglutaminase-protein G variant
The fragment antigen-binding (Fab) fragment of IgG has been studied widely as a delivery vehicle for tumor-targeting drugs and dyes due to its high specificity and enhanced tumor penetration, which is attributed to its small size. Functionalizing Fab with chemical entities requires site-specific modification to preserve the binding ninity and ensure product homogeneity. In this study, we report a tag-free, site-specific labeling approach targeting a Lys residue in Fab using the recently developed engineered zymogen of microbial transglutaminase fused with an antibody-binding protein G. Fab of trastuzumab, prepared via papain digestion, was selectively modified at Lys 65 in the heavy chain with a glutamine-donor fluorescent substrate, achieving a high labeling efficiency (∼96 %). Bio-layer interferometry experiments confirmed that the modified Fab retained antigen-binding affinity (KD = 5.71 ± 3.89 nM) comparable to its native counterpart (4.72 ± 3.19 nM). Confocal microscopy analysis demonstrated selective binding of the fluorescent-modified Fab to human epidermal growth factor receptor type2 (HER2)-positive SK-BR-3 cells, with negligible binding to HER2-negative MDA-MB-231 cells. The proposed strategy enables site-specific Fab modification without genetic engineering, offering a streamlined approach to producing homogeneous Fab conjugates for diagnostic imaging and therapeutic antibody engineering applications.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
New biotechnology
New biotechnology 生物-生化研究方法
CiteScore
11.40
自引率
1.90%
发文量
77
审稿时长
1 months
期刊介绍: New Biotechnology is the official journal of the European Federation of Biotechnology (EFB) and is published bimonthly. It covers both the science of biotechnology and its surrounding political, business and financial milieu. The journal publishes peer-reviewed basic research papers, authoritative reviews, feature articles and opinions in all areas of biotechnology. It reflects the full diversity of current biotechnology science, particularly those advances in research and practice that open opportunities for exploitation of knowledge, commercially or otherwise, together with news, discussion and comment on broader issues of general interest and concern. The outlook is fully international. The scope of the journal includes the research, industrial and commercial aspects of biotechnology, in areas such as: Healthcare and Pharmaceuticals; Food and Agriculture; Biofuels; Genetic Engineering and Molecular Biology; Genomics and Synthetic Biology; Nanotechnology; Environment and Biodiversity; Biocatalysis; Bioremediation; Process engineering.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信